Heparan sulfate-binding sites on extracellular matrix proteins (HS-binding sites)

Heparan sulfate-binding sites on extracellular matrix (ECM) proteins and related skin components represent a critical functional target in regenerative medicine and dermatology. These sites are specific amino acid motifs, such as the Cardin-Weintraub motif, found on structural proteins like collagen, fibronectin, and laminin, as well as on signaling molecules including fibroblast growth factors (FGFs) and vascular endothelial growth factors (VEGFs) [3, 5, 17]. In healthy skin, these sites are occupied by endogenous heparan sulfate (HS), which stabilizes the ECM scaffold and sequesters growth factors to regulate their bioavailability and protect them from proteolysis [10, 15]. Following injury or during aging, increased activity of enzymes like heparanase leads to the degradation of HS, leaving these binding sites vacant and rendering the ECM and growth factors susceptible to rapid degradation by proteases [1, 5, 6]. Therapeutic strategies, such as Matrix Therapy, utilize heparan sulfate mimetics like ReGeneraTing Agents (RGTAs, e.g., OTR4120) to target these vacant sites [1, 7]. By binding to these motifs, the mimetics replace the degraded natural HS, thereby protecting the ECM from further breakdown and restoring the protective niche for growth factors [2, 5]. This action facilitates the re-establishment of tissue homeostasis, accelerates wound healing, and improves skin quality in conditions such as chronic ulcers, photodamage, and surgical wounds [4, 11, 12].

Other names

Heparan sulfate-binding motifsHS-binding domainsHeparin-binding sitesECM HS-binding sitesVacant HS-binding sitesHeparan sulfate-binding sites on extracellular matrix proteins and related HS-interacting skin components

Binding to and stabilizing vacant heparan sulfate-binding sites on extracellular matrix proteins and growth factors to restore the cellular microenvironment and promote tissue regeneration.